BBB

BIO-WORKS TECHNOLOGIES AB

No trades
See on Supercharts
Market capitalization
‪147.34 M‬SEK
−1.53SEK
‪−54.82 M‬SEK
‪43.90 M‬SEK
Beta (1Y)
−0.39

About BIO-WORKS TECHNOLOGIES AB

CEO
Jonathan Royce
Headquarters
Uppsala
Employees (FY)
38
Founded
2013
ISIN
SE0007387089
FIGI
BBG00HZN67Z3
Bio-Works Technologies AB engages in the research and development, manufacturing, and supply of agarose-based resins. Its products include Size Exclusion and Ion Exchange Chromatography; IMAC and Activated resin; OptioBio Glass and BabyBio Columns; and Affinity Chromatography. The company was founded by Jan Hakan Berglöf in 2006 and is headquartered in Uppsala, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BIOWKS is 3.90 SEK — it has increased by 3.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BIO-WORKS TECHNOLOGIES AB stocks are traded under the ticker BIOWKS.
BIOWKS stock is 16.27% volatile and has beta coefficient of −0.39. Check out the list of the most volatile stocks — is BIO-WORKS TECHNOLOGIES AB there?
BIO-WORKS TECHNOLOGIES AB revenue for the last quarter amounts to ‪23.40 M‬ SEK despite the estimated figure of ‪23.10 M‬ SEK. In the next quarter revenue is expected to reach ‪28.40 M‬ SEK.
Yes, you can track BIO-WORKS TECHNOLOGIES AB financials in yearly and quarterly reports right on TradingView.
BIOWKS stock has fallen by 0.76% compared to the previous week, the month change is a 10.14% fall, over the last year BIO-WORKS TECHNOLOGIES AB has showed a 79.53% decrease.
BIOWKS net income for the last quarter is ‪−26.05 M‬ SEK, while the quarter before that showed ‪−28.78 M‬ SEK of net income which accounts for 9.49% change. Track more BIO-WORKS TECHNOLOGIES AB financial stats to get the full picture.
Today BIO-WORKS TECHNOLOGIES AB has the market capitalization of ‪147.34 M‬, it has decreased by 4.84% over the last week.
No, BIOWKS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIOWKS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-WORKS TECHNOLOGIES AB stock right from TradingView charts — choose your broker and connect to your account.
BIOWKS reached its all-time high on Dec 1, 2021 with the price of 28.70 SEK, and its all-time low was 3.84 SEK and was reached on Apr 8, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 38.00 employees. See our rating of the largest employees — is BIO-WORKS TECHNOLOGIES AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIO-WORKS TECHNOLOGIES AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIO-WORKS TECHNOLOGIES AB stock shows the sell signal. See more of BIO-WORKS TECHNOLOGIES AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO-WORKS TECHNOLOGIES AB EBITDA is ‪−54.81 M‬ SEK, and current EBITDA margin is −124.85%. See more stats in BIO-WORKS TECHNOLOGIES AB financial statements.